Wuhan Thalys Medical Technology Overview

  • Founded
  • 2004
Founded
  • Status
  • Public
  • Employees
  • 1,390
Employees
  • Stock Symbol
  • 603716
Stock Symbol
  • Investments
  • 7
  • Share Price
  • $2.00
  • (As of Friday Closing)

Wuhan Thalys Medical Technology General Information

Description

Thalys Medical Technology Inc is an early-stage medical intensive service provider. The company specializes in intensive marketing services for medical testing, agents for in vitro diagnostic products, and research and development, production and sales of autonomous in vitro diagnostic products. The majority of the revenue is earned from its in-service medical inspection intensive marketing and services.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Stock Exchange
SHG
Primary Office
  • 1310 Jinshan Avenue
  • East Lake, Dongxihu
  • Wuhan, 430040
  • China
+86 00000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Wuhan Thalys Medical Technology Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.00 $2.00 $1.65 - $2.76 $410M 205M 1.78M $0.04

Wuhan Thalys Medical Technology Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 607,685 630,312 551,800 566,333
Revenue 384,853 307,655 264,959 199,152
EBITDA 39,995 33,603 42,488 36,107
Net Income 8,012 8,332 15,981 14,234
Total Assets 612,697 597,912 429,776 375,463
Total Debt 219,652 214,124 125,989 100,367
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Wuhan Thalys Medical Technology Executive Team (2)

Name Title Board Seat Contact Info
Wenhao Liu Chief Financial Officer, Deputy General Manager & In-charge of Supervision, Audit & Compliance Center
Zheng Wang Executive Vice President
To view Wuhan Thalys Medical Technology’s complete executive team members history, request access »

Wuhan Thalys Medical Technology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Wuhan Thalys Medical Technology Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 15-Mar-2021 00000 00000 00 00000 Diagnostic Equipment
0000000000 13-Jan-2021 00000 00000 00 0000 Other Devices and Supplies 00000 0000
00000 19-Aug-2019 00000 00000 00 Educational Software
00000 000000 21-May-2019 00000 00000 00 0000 Information Services (B2C)
Wuhan Aoshenbo Technology 03-Aug-2017 Merger/Acquisition 00.000 Distributors/Wholesale
You’re viewing 5 of 7 investments and acquisitions. Get the full list »